ACE and diabetes mellitus: Also, posthoc analyses of other patient subgroups (patients with diabetes, patients aged > 70 years, female patients, and those with a cardiac device or using an ACE inhibitor/ AT-1 blocker) revealed no significant intervention effect on the primary study endpoint, Table 6 (all p > 0.05).